BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22639171)

  • 1. Glioma stem cell research for the development of immunotherapy.
    Xu Q; Yuan X; Yu JS
    Adv Exp Med Biol; 2012; 746():216-25. PubMed ID: 22639171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dendritic cell therapy for malignant glioma].
    Yamanaka R; Homma J; Yajima N; Tsuchiya N; Tanaka R
    No To Shinkei; 2003 Sep; 55(9):771-80. PubMed ID: 14571839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell vaccines.
    Yamanaka R; Kajiwara K
    Adv Exp Med Biol; 2012; 746():187-200. PubMed ID: 22639169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell- and peptide-based immunotherapeutic approaches for glioma.
    Yamanaka R
    Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell immunotherapy for malignant gliomas.
    Luptrawan A; Liu G; Yu JS
    Rev Recent Clin Trials; 2008 Jan; 3(1):10-21. PubMed ID: 18474011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy targeting glioma stem cells--insights and perspectives.
    Li Z; Lee JW; Mukherjee D; Ji J; Jeswani SP; Black KL; Yu JS
    Expert Opin Biol Ther; 2012 Feb; 12(2):165-78. PubMed ID: 22200324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine therapy with dendritic cells transfected with Il13ra2 mRNA for glioma in mice.
    Saka M; Amano T; Kajiwara K; Yoshikawa K; Ideguchi M; Nomura S; Fujisawa H; Kato S; Fujii M; Ueno K; Hinoda Y; Suzuki M
    J Neurosurg; 2010 Aug; 113(2):270-9. PubMed ID: 19895199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients.
    Lowenstein PR; Castro MG
    Clin Immunol; 2018 Apr; 189():43-51. PubMed ID: 28720549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell-based immunotherapy for malignant gliomas.
    Akasaki Y; Black KL; Yu JS
    Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cellular immunotherapy for malignant glioma].
    Okamoto Y; Yamashita J
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():557-62. PubMed ID: 16201581
    [No Abstract]   [Full Text] [Related]  

  • 11. Peptide vaccine.
    Izumoto S
    Adv Exp Med Biol; 2012; 746():166-77. PubMed ID: 22639167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic-cell- and peptide-based vaccination strategies for glioma.
    Yamanaka R
    Neurosurg Rev; 2009 Jul; 32(3):265-73; discussion 273. PubMed ID: 19214609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification of antigen against brain tumor stem cell and application for treatment of glioma].
    Toda M
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):1016-8. PubMed ID: 20597191
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model.
    Maes W; Van Gool SW
    Cancer Immunol Immunother; 2011 Feb; 60(2):153-60. PubMed ID: 21120655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with tumor cell lysate-pulsed dendritic cells augments the effect of IFN-beta gene therapy for malignant glioma in an experimental mouse intracranial glioma.
    Saito R; Mizuno M; Nakahara N; Tsuno T; Kumabe T; Yoshimoto T; Yoshida J
    Int J Cancer; 2004 Sep; 111(5):777-82. PubMed ID: 15252850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel immunotherapeutic approaches to glioma.
    Yamanaka R
    Curr Opin Mol Ther; 2006 Feb; 8(1):46-51. PubMed ID: 16506525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for malignant gliomas.
    Alavi JB; Eck SL
    Hematol Oncol Clin North Am; 1998 Jun; 12(3):617-29. PubMed ID: 9684101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumour stem cells in glioma--tomorrow's therapeutic target?].
    Christensen K; Schrøder HD; Kristensen BW
    Ugeskr Laeger; 2008 Sep; 170(38):2968-70. PubMed ID: 18808750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell vaccination in patients with malignant gliomas: current status and future directions.
    de Vleeschouwer S; Rapp M; Sorg RV; Steiger HJ; Stummer W; van Gool S; Sabel M
    Neurosurgery; 2006 Nov; 59(5):988-99; discussioin 999-1000. PubMed ID: 17143233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
    Zhao B; Bian EB; Li J; Li J
    J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.